Literature DB >> 28351385

Erratum to: Cancer progression by breast tumors with Pit-1-overexpression is blocked by inhibition of metalloproteinase (MMP)-13.

Juan Sendon-Lago1, Samuel Seoane1, Noemi Eiro2, Maria A Bermudez1, Manuel Macia3, Tomas Garcia-Caballero4, Francisco J Vizoso2, Roman Perez-Fernandez5.   

Abstract

Entities:  

Year:  2017        PMID: 28351385      PMCID: PMC5369202          DOI: 10.1186/s13058-017-0834-5

Source DB:  PubMed          Journal:  Breast Cancer Res        ISSN: 1465-5411            Impact factor:   6.466


× No keyword cloud information.

Erratum

After the publication of this work [1] an error was noticed in Fig. 4d and 4f. In the migration and invasion assays the same image was used accidentally for the Pit-1 + shMMP-1 and Pit-1 + shMMP-13. The corrected figure is shown below. The error does not affect the findings or conclusion of the article. We apologize for this error.
Fig. 4

MMP-1 and MMP-13 knockdown reduces invasive features in MCF-7 cells with Pit-1 overexpression, and in MDA-MB-231 cells. a-b Wound-healing assay in (a) MCF-7 cells with Pit-1 overexpression (pRSV-hPit-1), and knockdown of MMP-1 (shMMP-1(1) and shMMP-1(2)) and MMP-13 (shMMP-13(1) and shMMP-13(2)); (B) MDA-MB-231 cells with knockdown of Pit-1 (siPit-1), MMP-1 (shMMP-1(1) and shMMP-1(2)), and MMP-13 (shMMP-13(1) and shMMP-13(2)). Distance between the wound edges was measured at 48 hours in three different assays, and data are represented as mean ± SD; ns = not significant. c-d Cell motility through uncoated filters (migration) at 24 hours in control MCF-7 cells (pRcRSV), Pit-1-overexpressing MCF-7 cells (pRSV-hPit-1), and Pit-1-overexpressing and knockdown of MMP-1 or MMP-13 MCF-7 cells (pRSV-hPit-1 + shMMP-1 or −13). e-f Cell motility through matrigel-coated filters at 48 hours in control cells, cells transfected with the pRSV-hPit-1 vector, and cells transfected with pRSV-hPit-1 and knockdown of MMP-1 (Pit-1 + shMMP-1) or MMP-13 (Pit-1 + shMMP-13). Numbers represent mean ± SD. Scale bar: 100 μm. MMP-1, matrix metalloproteinase-1; MMP-13, matrix metalloproteinase-13; Pit-1, POU class 1 homeobox 1

MMP-1 and MMP-13 knockdown reduces invasive features in MCF-7 cells with Pit-1 overexpression, and in MDA-MB-231 cells. a-b Wound-healing assay in (a) MCF-7 cells with Pit-1 overexpression (pRSV-hPit-1), and knockdown of MMP-1 (shMMP-1(1) and shMMP-1(2)) and MMP-13 (shMMP-13(1) and shMMP-13(2)); (B) MDA-MB-231 cells with knockdown of Pit-1 (siPit-1), MMP-1 (shMMP-1(1) and shMMP-1(2)), and MMP-13 (shMMP-13(1) and shMMP-13(2)). Distance between the wound edges was measured at 48 hours in three different assays, and data are represented as mean ± SD; ns = not significant. c-d Cell motility through uncoated filters (migration) at 24 hours in control MCF-7 cells (pRcRSV), Pit-1-overexpressing MCF-7 cells (pRSV-hPit-1), and Pit-1-overexpressing and knockdown of MMP-1 or MMP-13 MCF-7 cells (pRSV-hPit-1 + shMMP-1 or −13). e-f Cell motility through matrigel-coated filters at 48 hours in control cells, cells transfected with the pRSV-hPit-1 vector, and cells transfected with pRSV-hPit-1 and knockdown of MMP-1 (Pit-1 + shMMP-1) or MMP-13 (Pit-1 + shMMP-13). Numbers represent mean ± SD. Scale bar: 100 μm. MMP-1, matrix metalloproteinase-1; MMP-13, matrix metalloproteinase-13; Pit-1, POU class 1 homeobox 1
  1 in total

1.  Cancer progression by breast tumors with Pit-1-overexpression is blocked by inhibition of metalloproteinase (MMP)-13.

Authors:  Juan Sendon-Lago; Samuel Seoane; Noemi Eiro; Maria A Bermudez; Manuel Macia; Tomas Garcia-Caballero; Francisco J Vizoso; Roman Perez-Fernandez
Journal:  Breast Cancer Res       Date:  2014-12-20       Impact factor: 6.466

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.